-
Modi pitches India as global chipmaking hub
-
King Charles to call on tech giants for 'reassurances' over AI
-
Ukraine plans record defence spending in 2027
-
STARPRIME Responds to Diverging Gold Market Demand with AM/PM Fixing and XAU24/7
-
NASA scan discovers new, 'once in a century' Moon crater
-
Where the US-China tariff row stands ahead of White House summit
-
Most stocks rise as Fed hikes and indicates drive to curb inflation
-
Indonesia cash-for-photos scheme turns animal hunters into protectors
-
UK-Sudanese author pens book to give children 'African history of Africa'
-
Argentine judge orders suspension of Falklands oil project
-
US Congress passes sweeping Russia sanctions bill
-
US Fed raises rates to tackle 'too high' inflation, irking Trump
-
US stocks fall, dollar gains after Fed lifts interest rates
-
Turkey releases 106 protesters, jails more LGBTQ activists
-
US Fed raises rates to tackle 'too high' inflation in move sure to rile Trump
-
Candidate for UN chief calls for AI regulation akin to nuclear weapons
-
US Fed raises rates to battle inflation in move likely to rile Trump
-
'We're losing control,' AI pioneer Yoshua Bengio tells AFP
-
US House faces test on sweeping Russia sanctions bill
-
IR-MED and Dice Technologies Announce collaboration to Evaluate and Advance Pressure-Injury Prevention Platform in Japan
-
British PM says to make 'difficult decisions' as inflation rises
-
Watts, Pitt, Cruz to light up Spain's top film festival
-
Global fuel price demos: a round-up
-
Toogood Gold's Table Mountain Sits in the Shadow of a Nevada Gold Rush
-
Leverate Launches MCP for Traders to Connect AI Assistants With Trading Platforms
-
MEXC July–August Security Report: 38.66M USDT in Risk Funds Intercepted, Futures Insurance Fund Hits 792M USDT
-
MEXC Launches $1M "Discover Your Wall Street DNA" Campaign to Help Traders Find Their Market Fit
-
Emporio Armani names Dario Vitale new creative director
-
Stocks edge higher ahead of US Fed rate call
-
EU to ban social media for under 13s, curb access until 15
-
BASIS.pro Expands On-Chain Infrastructure with XDC Network Partnership and Zypher DAO as Auto Earn Goes Live
-
Wildfires push endangered Sumatran elephants to brink: Indonesian NGO
-
Pickle-flavoured tart? AI inspires Japan's convenience stores
-
Bank of Japan set to raise rates under pressure from inflation, US
-
EU chief hosts Canada's Carney in push to 'deepen' alliance
-
EU chief to unveil social media, gaming curbs for under-15s
-
Meta chief pushes back on AI slowdown calls
-
'Resident Evil' film brings video game's ethos to the big screen
-
US Fed to deliver rate decision with markets betting on hike
-
GA-ASI Mojave First UAS To Complete Battlefield Short Field Ops
-
i-payout Expands U.S. Money Transmitter Licensing Footprint and Advances European EMI Strategy
-
Sanders, Bannon warn of AI dangers in rare US left-right alignment
-
US Senate crypto bill collapses amid partisan deadlock
-
Empty benches as schools reopen in Venezuela's quake-hit Guaira
-
OpenAI, Anthropic and Google are working to create an AI standards body
-
Tiny English village holds 'independence' vote over asylum seeker housing
-
Protesting shepherds, farmers clash with Romanian police
-
US Treasury chief says to meet Chinese counterpart at weekend
-
Foundation Lets Ledger Users Switch to Open Source Without Starting Over
-
BingX Evolves into a Multi-Asset Trading Platform, Connecting Users to Global Opportunities
Scientist who led team that created Dolly the cloned sheep dies at 79
The British scientist who led the team that created Dolly the sheep, a breakthrough in cloning, has died at the age of 79, his former university said on Monday.
Ian Wilmut, who revealed in 2018 he had been diagnosed with Parkinson's disease, helmed the team at the Roslin Institute at the University of Edinburgh in Scotland, which cloned Dolly in 1996.
Dolly was the first mammal to be cloned from an adult cell, and the breakthrough garnered global headlines and led to new advances in animal and medical research.
Peter Mathieson, the vice-chancellor of Edinburgh University, hailed Wilmut as "a titan of the scientific world" whose work cloning Dolly "transformed scientific thinking at the time".
"This breakthrough continues to fuel many of the advances that have been made in the field of regenerative medicine that we see today," he said in a statement.
Bruce Whitelaw, the current head of the Roslin Institute, said it was "sad news".
"Science has lost a household name," he added.
Wilmut retired from Edinburgh University of 2012.
But in 2018, he announced support for new research into Parkinson's, revealing he had diagnosed with the uncurable, progressive brain disorder, which can cause uncontrollable movements such as shaking.
"There was a sense of clarity, well at least now we know and we can start doing things about it," Wilmut told the BBC at the time.
"As well as obviously the disappointment that it will possibly shorten my life slightly, and more particularly it will alter the quality of life."
Parkinson's is the second most common neurodegenerative disease after Alzheimer's and affects more than 8.5 million people worldwide, according to the World Health Organization (WHO).
Ch.Lefebvre--CPN